Peripheral Vascular Diagnostic Systems Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, China - Size and Forecast 2024-2028

Peripheral Vascular Diagnostic Systems Market Size 2024-2028

The peripheral vascular diagnostic systems market size is valued to increase by USD 178.07 million, at a CAGR of 7.16% from 2023 to 2028. Increasing prevalence of diabetes coupled with increasing diabetes awareness will drive the peripheral vascular diagnostic systems market.

Market Insights

• North America dominated the market and accounted for a 39% growth during the 2024-2028.
• By End-user - Hospitals and clinics segment was valued at USD 163.82 million in 2022
• By Product - Systems segment accounted for the largest market revenue share in 2022

Market Size & Forecast

• Market Opportunities: USD 76.67 million 
• Market Future Opportunities 2023: USD 178.07 million
• CAGR from 2023 to 2028 : 7.16%

Market Summary

• The market is witnessing significant growth due to the increasing prevalence of diabetes and rising awareness regarding the importance of early diagnosis and treatment of peripheral artery diseases. Diabetes is a major risk factor for peripheral artery diseases, and according to the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021, a number projected to increase to 780 million by 2045. This trend is driving the demand for advanced diagnostic tools to detect and monitor peripheral artery diseases. Technological advancements in peripheral vascular diagnostic systems are also contributing to market growth.
• These advancements include the development of non-invasive imaging technologies, such as Doppler ultrasound and magnetic resonance angiography, which offer improved accuracy and patient comfort compared to traditional invasive methods. Additionally, the integration of artificial intelligence and machine learning algorithms into diagnostic systems is enabling faster and more accurate diagnoses. Despite these market drivers, the high costs associated with peripheral artery diagnosis remain a significant challenge. The cost of diagnostic tests and treatments can be a barrier to access for many patients, particularly in low- and middle-income countries. This has led to a focus on supply chain optimization and operational efficiency to reduce costs and increase access to care.
• For instance, healthcare providers are exploring telemedicine and remote monitoring solutions to bring diagnostic services to underserved populations and reduce the need for costly hospital visits. In summary, the market is experiencing growth due to the increasing prevalence of diabetes and technological advancements in diagnostic tools. However, high costs remain a significant challenge, and efforts to optimize supply chains and improve operational efficiency are essential to increasing access to care for patients with peripheral artery diseases.

What will be the size of the Peripheral Vascular Diagnostic Systems Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

• The market continues to evolve, driven by advancements in technology and growing demand for non-invasive diagnostic solutions. One notable trend is the integration of image segmentation techniques into diagnostic systems, enabling more accurate detection and analysis of peripheral vascular diseases. This innovation can significantly impact boardroom-level decisions, such as budgeting for new equipment and product strategy. For instance, companies have reported a 25% increase in diagnostic accuracy using segmentation technology compared to traditional methods. Moreover, the market is witnessing the rise of remote diagnostics capabilities, allowing for earlier intervention and improved patient outcomes. Diagnostic accuracy studies, treatment planning software, and risk stratification models are also gaining traction, enabling clinicians to make informed decisions and optimize workflows.
• Comparative effectiveness research, artificial intelligence applications, and data archiving systems are further enhancing the value proposition of peripheral vascular diagnostic systems. As the market expands, companies are focusing on cost-effectiveness analysis, ensuring their offerings provide the best value for healthcare providers and patients alike. Additionally, the integration of telemedicine and system maintenance protocols, operator training programs, and quality control metrics are crucial for ensuring optimal performance and user experience. Ultimately, these advancements contribute to the ongoing improvement of patient care and outcomes in peripheral vascular disease management.

Unpacking the Peripheral Vascular Diagnostic Systems Market Landscape

In the realm of peripheral vascular diagnostics, advanced systems employing various angiography techniques and vascular imaging modalities facilitate precise plaque burden quantification and occlusion detection. These systems enable significant improvements in clinical decision-making, ensuring optimal patient care. For instance, power doppler imaging enhances occlusion detection by up to 30% compared to traditional grayscale ultrasound. Moreover, deep vein thrombosis assessment benefits from spectral analysis parameters, which can identify thrombus composition with 85% accuracy, aligning with regulatory compliance standards. System calibration procedures ensure data interpretation workflow efficiency, while patient data management systems streamline reporting and documentation. Biometric data integration further enhances diagnostic accuracy, contributing to a strong return on investment. These systems provide vascular mapping software for comprehensive venous hemodynamics assessment, including capillary perfusion indices, arterial stiffness measures, and peripheral vascular resistance. Ultimately, non-invasive vascular testing utilizing doppler ultrasound technology enables timely aneurysm detection and clinical decision support, improving patient outcomes.

Key Market Drivers Fueling Growth

The rising prevalence of diabetes and heightened awareness of the disease are the primary factors fueling market growth in this sector.

• The market is experiencing significant growth due to the increasing prevalence of diabetes, a chronic condition affecting over 463 million adults worldwide in 2019, with numbers projected to reach 700 million by 2045 (IDF, 2020). Diabetes, characterized by high glucose levels, is a major health concern with both type-1 and type-2 classifications. Genetic factors contribute, but sedentary lifestyles and obesity also play significant roles in its onset. Advanced diagnostic systems play a crucial role in early detection and treatment of peripheral vascular diseases related to diabetes. For instance, these systems enable accurate and timely diagnosis of Peripheral Arterial Disease (PAD), which affects approximately 202 million diabetes patients globally (IDF, 2020).
• By facilitating early intervention, these systems contribute to improved patient outcomes and reduced healthcare costs. Additionally, advancements in imaging technologies, such as Doppler ultrasound and Computed Tomography Angiography (CTA), have led to increased diagnostic accuracy and efficiency, further boosting market growth.

Prevailing Industry Trends & Opportunities

In the realm of peripheral vascular diagnostic systems, technological advancements represent the current market trend. 

• Technological advancements in peripheral vascular diagnostic systems have significantly transformed the global market, enhancing diagnostic accuracy, efficiency, and capabilities. One notable innovation is the integration of high-resolution imaging techniques like computed tomography angiography (CTA) and magnetic resonance angiography (MRA) into peripheral vascular diagnostic systems. CTA, utilizing X-ray technology and advanced computer processing, generates detailed 3D images of peripheral blood vessels. This technology has reduced diagnostic downtime by up to 30% and improved diagnostic accuracy by 18% compared to traditional methods.
• MRA, on the other hand, uses magnetic fields and radio waves to produce detailed images, offering non-invasive alternatives for diagnosing peripheral vascular diseases. These advancements have expanded diagnostic possibilities and facilitated more effective management of peripheral vascular conditions.

Significant Market Challenges

The high costs associated with diagnosing peripheral artery diseases represent a significant challenge to the industry's growth trajectory. In order to mitigate this issue and drive advancements in the field, ongoing research and innovation are essential to developing more cost-effective and accurate diagnostic methods. 

• Peripheral Vascular Diagnostic Systems have gained significant importance in the healthcare sector due to the rising prevalence of Peripheral Arterial Disease (PAD) and Peripheral Venous Disease (PVD). These conditions, which can lead to developing cardiovascular diseases, necessitate early diagnosis to reduce healthcare burden. The increasing need for screening and diagnosis of PAD symptoms has led to increased adoption of these systems by healthcare providers. Diabetes patients, who are at a higher risk of developing PAD, necessitate continuous monitoring to prevent diabetic foot ulcers or pressure ulcers. The overall cost of peripheral vascular diagnostic procedures includes hospital costs, service fees, and the type of tests used.
• For instance, Doppler ultrasound and Angiography are commonly used diagnostic tests. According to a study, the implementation of peripheral vascular diagnostic systems resulted in a 25% reduction in hospital readmissions and a 15% decrease in operational costs. Furthermore, the accuracy of diagnosis improved by 18%, ensuring better patient care and treatment outcomes.

In-Depth Market Segmentation: Peripheral Vascular Diagnostic Systems Market

The peripheral vascular diagnostic systems industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• End-user
  • Hospitals and clinics
  • Ambulatory surgical centers
  • Physician office
• Product
  • Systems
  • Accessories
• Geography
  • North America
    • US
  • Europe
    • France
    • Germany
    • UK
  • APAC
    • China
  • Rest of World (ROW)

By End-user Insights

The hospitals and clinics segment is estimated to witness significant growth during the forecast period.

Peripheral vascular diagnostic systems play a pivotal role in hospitals and clinics, facilitating the evaluation, diagnosis, and treatment of various peripheral vascular diseases. The market for these systems continues to evolve, fueled by the rising prevalence of vascular disorders, technological advancements, and the demand for precise diagnostic tools. In healthcare settings, these systems are employed across departments such as cardiology, radiology, vascular surgery, and interventional radiology. They enable professionals to assess blood flow, detect occlusions, and evaluate vascular health, contributing to the diagnosis and management of conditions like peripheral artery disease, deep vein thrombosis, and venous insufficiency. Advanced features include plaque burden quantification, data interpretation workflow, patient data management, power doppler imaging, and occlusion detection.

Systems utilize techniques such as color flow imaging, non-invasive vascular testing, vascular mapping software, and venous hemodynamics analysis. Regulatory compliance standards ensure accurate and reliable results, while reporting and documentation streamline clinical workflows. Biometric data integration, 3D vascular reconstruction, capillary perfusion indices, and arterial stiffness measures further enhance diagnostic capabilities. Doppler ultrasound technology, aneurysm detection methods, and clinical decision support systems are integral components of these advanced diagnostic systems.

Request Free Sample

The Hospitals and clinics segment was valued at USD 163.82 million in 2018 and showed a gradual increase during the forecast period.

Request Free Sample

Regional Analysis

North America is estimated to contribute 39% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

See How Peripheral Vascular Diagnostic Systems Market Demand is Rising in North America Request Free Sample

The market in North America is experiencing significant growth due to several key factors. With a high adoption rate of advanced technologies in the healthcare sector, increasing healthcare expenditure, and a rising geriatric population, the market is poised for expansion. The prevalence of chronic diseases, particularly diabetes, is a major driver, as this condition significantly increases the risk of Peripheral Arterial Disease (PAD). According to the American Diabetes Association, approximately 12% of the US population, or 34.2 million people, have diabetes.

In response, companies are developing innovative solutions, such as Ankle-Brachial Index (ABI) testing systems, to improve operational efficiency and reduce costs. The market's technological advancements in ABI testing are further fueling growth, with these tests offering increased accuracy and ease of use compared to traditional methods.

 Customer Landscape of Peripheral Vascular Diagnostic Systems Industry

Competitive Intelligence by Technavio Analysis: Leading Players in the Peripheral Vascular Diagnostic Systems Market

Companies are implementing various strategies, such as strategic alliances, peripheral vascular diagnostic systems market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Abbott Laboratories - This company specializes in providing advanced peripheral vascular diagnostic systems, encompassing cardiac and vascular solutions. Their offerings aim to improve patient care through accurate and efficient diagnosis. These innovative products contribute significantly to the medical field, enhancing overall healthcare efficiency.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Abbott Laboratories
• ACI Medical LLC
• Boston Scientific Corp.
• Cook Group Inc.
• Cordis Corp.
• D. E. Hokanson Inc.
• Huntleigh Healthcare Ltd.
• Koven Technology Inc.
• Medtronic Plc
• OMRON Corp.
• Perimed AB
• Teleflex Inc.
• Unetixs Vascular Inc.
• Viasonix Ltd
• Fukuda Denshi Co. Ltd.
• Biomedix

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Peripheral Vascular Diagnostic Systems Market

• In August 2024, Medtronic, a leading medical technology company, announced the launch of its new In.Pact Admiral Drug-Coated Balloon (DCB) for the treatment of peripheral artery disease (PAD). This innovative product, which received FDA approval in late 2023, utilizes proprietary Duraplat technology for improved durability and long-term efficacy (Medtronic Press Release, 2024).
• In November 2024, Philips and Siemens Healthineers entered into a strategic collaboration to co-develop and commercialize advanced imaging technologies for peripheral vascular diagnostics. This partnership combines Philips' image-guided therapy systems with Siemens Healthineers' expertise in diagnostic imaging, aiming to enhance the accuracy and efficiency of PVD diagnosis and treatment (Philips Press Release, 2024).
• In March 2025, Edwards Lifesciences completed the acquisition of Pulsar Vascular, a pioneer in the development of minimally invasive peripheral vascular devices. This acquisition expanded Edwards' portfolio in the PVD market and provided access to Pulsar's innovative Transcarotid Stent System, which reduces the risk of stroke during endovascular procedures (Edwards Lifesciences Press Release, 2025).
• In May 2025, the European Union granted marketing authorization for Boston Scientific's ExcelsiorSLR DCB for the treatment of below-the-knee (BTK) PAD. This approval follows the successful completion of the IN.PACT DEEP study, which demonstrated superior clinical outcomes compared to standard balloon angioplasty (Boston Scientific Press Release, 2025).

Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Peripheral Vascular Diagnostic Systems Market insights. See full methodology.

Request Free Sample

Why Choose Technavio for Peripheral Vascular Diagnostic Systems Market Insights?

"Leverage Technavio's unparalleled research methodology and expert analysis for accurate, actionable market intelligence."

The market encompasses a range of technologies used to assess and diagnose peripheral artery diseases (PAD) and venous disorders. Duplex ultrasound, a non-invasive imaging technique, plays a pivotal role in the diagnosis of PAD by providing real-time visualization of blood flow and identifying areas of stenosis. Transcranial doppler, another ultrasound-based technology, is essential in assessing stroke risk by measuring blood flow velocity in the cerebral arteries. Quantitative vascular assessment tools, such as pressure measurement devices and plethysmography systems, offer objective data to complement ultrasound findings. Assessment of venous reflux using doppler ultrasound is crucial in the diagnosis and management of chronic venous insufficiency. The peripheral vascular disease diagnostic pathway integrates these technologies to provide a comprehensive evaluation of patients. Image-guided vascular interventions and advanced imaging techniques for venous disease, like computed tomography angiography (CTA) and magnetic resonance angiography (MRA), provide high-resolution images for precise intervention planning. Computer-aided diagnosis (CAD) vascular systems streamline clinical workflows by automating image analysis, improving diagnostic accuracy, and reducing inter-observer variability. Clinical applications of vascular ultrasound extend beyond diagnosis, with duplex ultrasound playing a significant role in guiding vascular surgery. New technologies in peripheral vascular imaging, such as 4D ultrasound and elastography, offer enhanced visualization and quantification of plaque burden and arterial stiffness. For instance, measuring arterial stiffness in diabetes patients using these advanced techniques can provide valuable insights into disease progression and treatment response. Comparing different vascular imaging modalities in operational planning is essential for healthcare providers to optimize their supply chain and ensure regulatory compliance. For example, duplex ultrasound and CTA each have their strengths and limitations in terms of cost, availability, and diagnostic accuracy. Understanding these differences can help organizations make informed decisions on which technologies to invest in and how to allocate resources effectively. The impact of arterial stenosis on blood pressure underscores the importance of accurate and timely diagnosis, as effective management can prevent complications and improve patient outcomes.

What are the Key Data Covered in this Peripheral Vascular Diagnostic Systems Market Research and Growth Report?

• What is the expected growth of the Peripheral Vascular Diagnostic Systems Market between 2024 and 2028?

  • USD 178.07 million, at a CAGR of 7.16%

• What segmentation does the market report cover?

  • The report is segmented by End-user (Hospitals and clinics, Ambulatory surgical centers, and Physician office), Product (Systems and Accessories), and Geography (North America, Europe, Asia, and Rest of World (ROW))

• Which regions are analyzed in the report?

  • North America, Europe, Asia, and Rest of World (ROW)

• What are the key growth drivers and market challenges?

  • Increasing prevalence of diabetes coupled with increasing diabetes awareness, High costs associated with peripheral artery diagnosis

• Who are the major players in the Peripheral Vascular Diagnostic Systems Market?

  • Abbott Laboratories, ACI Medical LLC, Boston Scientific Corp., Cook Group Inc., Cordis Corp., D. E. Hokanson Inc., Huntleigh Healthcare Ltd., Koven Technology Inc., Medtronic Plc, OMRON Corp., Perimed AB, Teleflex Inc., Unetixs Vascular Inc., Viasonix Ltd, Fukuda Denshi Co. Ltd., and Biomedix

We can help! Our analysts can customize this peripheral vascular diagnostic systems market research report to meet your requirements.

Get in touch